Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
78
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Astria Therapeutics Inc market cap is $718.13M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Astria Therapeutics Inc 52 week high is $13.29 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Astria Therapeutics Inc 52 week low is $3.56 as of November 22, 2026.
Astria Therapeutics Inc stock price today is $12.56.
Astria Therapeutics Inc stock price yesterday was $12.50.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Astria Therapeutics Inc's P/E ratio is -5.85.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Astria Therapeutics Inc P/B ratio is 5.1472.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Astria Therapeutics Inc 50-day moving average is $12.75.